The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.

A 53-year-old woman was the third to undergo the transplant procedure. Researchers are hoping to monitor the long-term effects.

Startup Phantom Neuro is building an implant that sits under the skin and which promises to give amputees more accurate control of electronic prosthetics.

The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.